Are you an Alien? Earth to the funny looking guy who is losing his money in the stock market. Get your head out of the sand.
When you are in an extreme mode of denial you are putting your head in the sand but exposing your #$%$ Good luck with that, but remember 80 million Japanese would strongly disagree with you. Lol.
The Restricted Stock units (RSU) were issued after certain performance initiatives were achieved. Oct. 5th, wasn't that a deadline for an appeal of the 1A case? Hmmmm. Sometimes you have to read between the lines.
So you are calling the AHA pumpers? What does that tell you? You certainly can't call repeating facts as pumping since pumping would be inflating the facts not just repeating statements of facts made by qualified, respected, scientific organizations.
I have noticed the five digit buys late in the afternoon. Can you make make a purchase that specific? No. Furthermore, how many times has the S/P risen to the close? Someone is taking advantage of the low S/P.
People with existing heart disease should consider taking omega-3 fatty acid supplements (850 - 1,000 mg/day of EPA and DHA). For people with high triglyceride levels, higher doses (2 - 4 g/day) may be appropriate. The AHA recommends against taking antioxidant vitamin supplements (C, E, beta-carotene) or folic acid supplements for prevention of heart disease.
Source: Heart-healthy diet | University of Maryland Medical Center
University of Maryland Medical Center
Great advice from the AHA. Guess they never sent the memo to the FDA.
Also, late afternoon buys four digits to the right of the decimal point is institutional activity. Everyday they take advantage of the low S/P and every afternoon the S/P rises to the close. Do they know something that we do not?
I don't blame you for being angry. All the large hedge funds have abandoned their short positions. Institutions are stealthily buying, even investors like the Baker Bros. it seems that their diligent research was correct about the FDA situation and will soon pay them handsomely. It is really a shame when these news letter services use the small retail shorts and take advantage of their ignorance. Good luck.
The University of Maryland Medical Center also notes that the EPA in fish oil has been implicated in cholesterol reduction and a resulting improvement in heart disease. EPA acts to lower the triglyceride levels in the blood. This decrease in triglyceride levels means that there is potential for decrease in cholesterol formation--important because high cholesterol levels are related to plaque build-up in the body which can result in stroke and heart disease.
Something else to get depressed about.
Also, think of a major drug company with a statin that has, or is about to run out of exclusivity wouldn't be a bad idea to buy Amarin and create a new combo. Drug.
Amarin Announces Completion of Dosing in a Fixed-Dose Combination Study With Vascepa(R) and a Leading Statin
BEDMINSTER, N.J., and DUBLIN, Ireland, Dec. 17, 2012 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that it has completed dosing and pharmacokinetic sampling in a study to test a fixed-dose combination of Vascepa® (icosapent ethyl) capsules and a leading statin. The clinical name for this combination product is AMR102. Prior to commencement of the study, Amarin opened an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration which became effective after the standard 30-day review.
The purpose of this AMR102 study is to determine the bioavailability of the EPA (eicosapentaenoic acid) and statin components when taken as a fixed-dose combination product, relative to the individual reference agents taken concomitantly. Statin bioavailability from both the fixed-dose and concomitant regimens will also be compared with that from the reference statin taken alone in healthy subjects. Additionally, pharmacokinetic data from this study will be examined to explore relationships between in vitro dissolution data and in vivo pharmacokinetic data. The study is designed as a randomized, open-label, multiple dose, parallel-group study in 48 healthy subjects conducted at a single site in the United States.
"This study is aimed at expanding the potential commercial application of Vascepa by leveraging the clinical successes of the MARINE and ANCHOR trials, namely effective triglyceride lowering without increasing LDL-C," stated Joseph Zakrzewski, Amarin's Chairman and Chief Executive Officer. "Amarin's goal is to identify ways for patients to simplify their lipid management by developing a single therapy that offers the powerful triglyceride lowering effects of Vascepa combined with one of the
Depression is a mental condition that ranges from mild to severe states of sadness. EPA found in fish oil has been shown to reduce symptoms of depression in some people. This benefit is most noticeable in those who have the most severe symptoms. Individuals with depression have been shown to have low levels of EPA in circulation. It is thought that by increasing the supply of EPA in the blood stream that brain function would be assisted. The recommended dosage varies, but a minimum of 100 mg to 300 mg of EPA is recommended. Fish oil is not a replacement for conventional treatment; however, it can be used to augment it according to Daniel Hall-Flavin of the Mayo Clinic.
Ironic that as the price of Amarin goes up the one thing that will give Shorts relief will help contribute to their misery.
What is going to happen when there is no more money in the cookie jar. They just keep taking, and taking and like an irresponsible teenager believe it will aways majically be there
Jellis study was done in a population that typically have very few cardiac events. Those few that did occur were made the data statistically insignificant and the benefits of vascepa could not be included. In the other studies the end point was lowering Trigs, not decreasing Cardiac events, because the FDA believed at the time that lowering Trigs would lower cardiac events. To date no study with Vascepa, in the proper population group, with the the proper doseage, and an end point of lowering Cardiac events has been completed. The RI study is the first with all the right criteria.
Also, consider this unusual drop in S/P. These things do not happen for no reason. If I am right we should see an increase in volume tomorrow and Friday morning.
Week before last they had over 1000 TRX increase. Last week they averaged just over 3000 scripts per day for 4 days. So, in conclusion it is in the realm of possibility of reaching 15,000 scripts this week. However, I am predicting 14,731.